A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras
- PMID: 8397201
A dominant-negative mutant of raf blocks mitogen-activated protein kinase activation by growth factors and oncogenic p21ras
Abstract
p74raf-1, a serine/threonine kinase, is structurally related to the protein kinase C (PKC) family and contains a cysteine motif in its N-terminal domain, which is essential for its regulation. It has been shown that p74raf-1 functions upstream of mitogen-activated protein (MAP) kinase kinase. We have constructed a p74raf-1 mutant (N delta raf) that only contains the N-terminal regulatory domain. When transiently expressed in COS-M6 cells, N delta raf efficiently blocked the activation of the MAP extracellular signal regulated kinase (ERK2), induced by either epidermal growth factor, phorbol ester, serum, or oncogenic p21ras. Similar constructs with the cysteine motifs from either PKC-alpha or diacylglycerol kinase did not inhibit activation of ERK2. Overexpression of full-length p74raf-1 rescued the inhibition of ERK2 by N delta raf in a stimulus dependent manner, indicating that N delta raf acts as a competitive inhibitor of wild-type p74raf-1. In contrast, overexpression of either PKC-alpha, -epsilon, or -zeta in N delta raf-containing cells could not rescue the inhibition of ERK2. We conclude that p74raf-1 is an essential mediator of epidermal growth factor- and phorbol ester-induced ERK2 activation and that the MAP kinase kinase activity of p74raf-1 cannot be substituted with either PKC-alpha, -epsilon or -zeta.
Similar articles
-
Activation of the MAP kinase pathway by the protein kinase raf.Cell. 1992 Oct 16;71(2):335-42. doi: 10.1016/0092-8674(92)90361-f. Cell. 1992. PMID: 1330321
-
Interleukin-1 activates p54 mitogen-activated protein (MAP) kinase/stress-activated protein kinase by a pathway that is independent of p21ras, Raf-1, and MAP kinase kinase.J Biol Chem. 1994 Dec 16;269(50):31836-44. J Biol Chem. 1994. PMID: 7527398
-
Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation.EMBO J. 1995 Jul 3;14(13):3136-45. doi: 10.1002/j.1460-2075.1995.tb07316.x. EMBO J. 1995. PMID: 7542586 Free PMC article.
-
Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C zeta and the vav and c-raf proto-oncogene products.J Biol Chem. 1994 Apr 15;269(15):11590-4. J Biol Chem. 1994. PMID: 8157692
-
Lysophosphatidic acid stimulates mitogen-activated protein kinase activation via a G-protein-coupled pathway requiring p21ras and p74raf-1.J Biol Chem. 1993 Oct 5;268(28):20717-20. J Biol Chem. 1993. PMID: 8407893
Cited by
-
Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment.Signal Transduct Target Ther. 2021 Dec 20;6(1):422. doi: 10.1038/s41392-021-00825-8. Signal Transduct Target Ther. 2021. PMID: 34924561 Free PMC article. Review.
-
Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer.J Cell Commun Signal. 2018 Sep;12(3):513-527. doi: 10.1007/s12079-017-0441-3. Epub 2018 Jan 12. J Cell Commun Signal. 2018. PMID: 29330773 Free PMC article. Review.
-
Effects of insulin on human pancreatic cancer progression modeled in vitro.BMC Cancer. 2014 Nov 6;14:814. doi: 10.1186/1471-2407-14-814. BMC Cancer. 2014. PMID: 25373319 Free PMC article.
-
Mitogen-Activated Protein (MAP) Kinase Scaffolding Proteins: A Recount.Int J Mol Sci. 2013 Mar 1;14(3):4854-84. doi: 10.3390/ijms14034854. Int J Mol Sci. 2013. PMID: 23455463 Free PMC article.
-
Therapeutic strategies for targeting ras proteins.Genes Cancer. 2011 Mar;2(3):359-72. doi: 10.1177/1947601911412376. Genes Cancer. 2011. PMID: 21779505 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
